Skip over main navigation
  • Log in
  • Basket: (0 items)
Emerge Australia
  • Twitter
  • Facebook
  • Email
Donate Become a member
Menu
  • About us
    • What we do
    • Our team
    • Our Ambassadors
      • Tracey Spicer
      • Bloom
    • Our impact
    • Annual reports
    • Position Statements
    • Contact us
  • Information
    • Post-Exertional Malaise
    • ME/CFS Information
    • Long COVID
    • Management
    • For health professionals
    • For carers
    • Member stories
  • Research
    • ME/CFS biobank and registry
    • Long COVID Registry
    • Research Digest
    • Get involved in Research
    • Health and Wellbeing Survey
  • How to get help
    • Patient Support and Information Services
    • Telehealth Nurse Service
    • Online Community
    • GP Education Program
    • Accessing financial support
      • About NDIS
      • About DSP
      • NDIS and DSP Application Resources
      • Debt Helplines
  • Get involved
    • Give monthly
    • Donate
    • Fundraisers
    • Gift In Will
    • Emerge Australia Membership
    • Volunteer with us
    • Patient Advisory Group
    • Campaigns and advocacy resources
    • ME/CFS Awareness Week
  • Forum
  • News
  • Admin
    • Log in
  • Basket: (0 items)
  • Long COVID Registry

Long COVID Registry

Are you still experiencing ongoing symptoms, 3 months after infection with SARS-CoV-2/Covid-19, with no other explanation?

In 2023, the Australian ME/CFS Biobank and Registry will expand to collect vital data and biosamples from patients who are experiencing symptoms of long-COVID.

By contributing to the Biobank and Registry, you will actively be helping to further research not just into long-COVID but ME/CFS and other post-infection diseases.

To be one of the first to hear about updates on the expansion, or express your interest in participating, please sign up using the form below.

Register your interest

The Mason Foundation-funded Biobank and Registry (You+ME Registry) was established by Emerge Australia and aims to create Australia’s largest database of patient-recorded data and biological samples, from those living with post-infection diseases. 

Our mission is to provide biomedical researchers with access to high-quality patient biospecimens and a comprehensive data registry to facilitate impactful research into Long COVID and post-infection diseases. 

The Registry is patient-driven, created by and for the people who use it, collecting detailed demographic and health information from individuals living in Australia. Using a secure web-based portal, Registry participants will provide data regarding their diagnosis, symptoms, medications, and lived experience with ME/CFS. This information is then made available to our approved researchers in a deidentified format. 

By being a Registry participant, you will be informed of any research opportunities that we believe you may be eligible for; such as clinical trials, research studies, and donating to the ME/CFS or Long COVID Biobanks. 

Carers and supporters of those with Long COVID are also warmly welcomed to contribute to the You+ME Registry as healthy volunteers. Healthy volunteers (aka: “controls” or people without Long COVID) are a critical part of research because it’s impossible to determine what it means to be sick, without knowing what it means to be healthy. 

If you would like to join the You+ME Registry or learn more about it or the ME/CFS Biobank, please visit our website below: 

www.emerge.org.au/biobank-registry 

Published: 20th December, 2022

Updated: 15th March, 2023

Author: Jonathan Stavridis

Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • Research Digest 30/3/23

    Research Digest 30/3/23

    Welcome to the Research Digest’s 93rd edition. This month's edition summarises research that investigates factors that influence the prognosis of ME/CFS and demonstrates that high muscle sodium content, maybe a contributing factor to the pathophysiology of ME/CFS. A review is also highlighted that conveys what is presently known about Long COVID and finally, a local study sheds light on brain structure changes that are common to Long COVID and ME/CFS.

  • Run Melbourne 2023

    Run Melbourne 2023

    We're participating in Run Melbourne 2023. Join now to help reach our goal by running, walking or performing your own activity with us!

  • GP Education at GPCE in 2023

    GP Education at GPCE in 2023

    We know how difficult it is to find a GP with knowledge of ME/CFS. One of the main aims for our GP education program is to grow the GP workforce confident to take on people with complex presentations.

  • Emerge Australia welcomes Tracey Spicer as an Ambassador

    We are thrilled to announce that Tracey Spicer, AM BBus(Comm) GAICD, has joined Emerge Australia in an ongoing ambassador role.https://www.emerge.org.au/GetImage.aspx?IDMF=1bd7f269-50e9-45e2-80dd-98297ba7ec05&w=427&h=640&src=mc

Most read

  • Contact Us

    Contact Us

    Emerge Australia provides an information line where you can find out about the latest news and information about ME/CFS.

  • What we do

    What we do

    Who we are and what we do

  • What is ME/CFS?

    What is ME/CFS?

    Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex and disabling disease that affects many parts of the body, including the brain and muscles, as well as the digestive, immune and cardiac systems, among others.

  • Post-Exertional Malaise (PEM)

    Post-Exertional Malaise (PEM)

    The central feature of ME/CFS, and a common symptom of Long COVID, is post-exertional malaise (PEM). PEM is when symptoms get worse after physical or mental activity.

  • Volunteer with us

    Volunteer with us

    Join our small, friendly and enthusiastic team as a volunteer

  • How is functional impairment assessed?

  • Annual reports

    Annual reports for Emerge Australia

  • What is ME/CFS?

    What is ME/CFS?

    Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex and disabling disease that affects many parts of the body, including the brain and muscles, digestive, immune and cardiac systems. ME is classified as a neurological disorder by the World Health Organization.

  • Coronavirus and ME - Simplified facts

    Coronavirus and ME - Simplified facts

    Many people with ME/CFS and other vulnerable communities in Australia are concerned about the impacts of the spreading coronavirus disease COVID-19. This is an easy-read resource with the latest information and advice.

  • Patient Advisory Group

    Patient Advisory Group

    The Patient Advisory Group provides Emerge Australia with ongoing advice about the needs of the community, as well as invaluable input into projects

Sign up to our newsletter

* indicates required


Specific mailing lists

Helpful links

  • Sitemap
  • Accessibility
  • Terms & Conditions
  • Privacy Policy

Connect with us

  • Twitter
  • Facebook
  • YouTube


Get in touch with us

Emerge Australia
Level 7, 276 Flinders Street
Melbourne VIC 3000
1800 865 321
03 9529 1344
[email protected]

Media enquiries contact Claire Heaney
Mobile: 0421 612 507
Email: [email protected]

Emerge Australia is registered as a charity with the Australian Charities and Not-for-profits Commission (ACNC). We are authorised by the Australian Tax Office as a deductible gift recipient (DGR). 

ABN/DGR: 22 385 438 041

Donations of $2 or more are tax-deductible. 

Emerge Australia acknowledges Aboriginal and Torres Strait Islander people as the Traditional Custodians of the land and pays respect to their Elders past and present.

© 2019 Emerge Australia. All rights reserved.

Manage Cookie Preferences